Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

SARS-CoV-2 reinfection caused by the P.1 lineage in Araraquara city, Sao Paulo State, Brazil

Full text
Author(s):
Show less -
Romano, Camila Malta [1, 2] ; Felix, Alvina Clara [2] ; de Paula, Anderson Vicente [2] ; de Jesus, Jaqueline Goes [2] ; Andrade, Pamela S. [2] ; Candido, Darlan [3, 2] ; de Oliveira, Franciane M. [2] ; Ribeiro, Andreia C. [4] ; da Silva, Francini C. [4] ; Inemami, Marta [4] ; Costa, Angela Aparecida [4] ; Leal, Cibele O. D. [2] ; Figueiredo, Walter Manso [4] ; Pannuti, Claudio Sergio [2] ; de Souza, William M. [5] ; Faria, Nuno Rodrigues [6, 7] ; Sabino, Ester Cerdeira [6, 2]
Total Authors: 17
Affiliation:
[1] Univ Sao Paulo, Hosp Clin, Fac Med, Sao Paulo, SP - Brazil
[2] Univ Sao Paulo, Inst Med Trop Sao Paulo, Av Dr Eneas Carvalho Aguiar 470, BR-05403000 Sao Paulo, SP - Brazil
[3] Univ Oxford, Dept Zool, Oxford - England
[4] Univ Sao Paulo, Serv Especial Saude Araraquara, Sao Paulo, SP - Brazil
[5] Univ Sao Paulo, Fac Med Ribeirao Preto, Ctr Pesquisa Virol, Ribeirao Preto, SP - Brazil
[6] Univ Sao Paulo, Fac Med, Dept Molestias Infecciosas & Parasitarias, Sao Paulo, SP - Brazil
[7] Imperial Coll London, MRC Ctr Global Infect Dis Anal, London - England
Total Affiliations: 7
Document type: Journal article
Source: Revista do Instituto de Medicina Tropical de São Paulo; v. 63, 2021.
Web of Science Citations: 6
Abstract

Reinfection by the severe acute respiratory syndrome coronavirus type 2 (SARS-COV-2) has been reported in many countries, suggesting that the virus may continue to circulate among humans despite the possibility of local herd immunity due to massive previous infections. The emergence of variants of concern (VOC) that are more transmissible than the previous circulating ones has raised particular concerns on the vaccines effectiveness and reinfection rates. The P.1 lineage was first identified in December 2020 in Manaus city and is now globally spread. We report the first case of reinfection of SARS-CoV-2 caused by the P.1 variant outside of Manaus. The potential of these new variants to escape naturally and vaccine-induced immunity highlights the need for a global vigilance. (AU)

FAPESP's process: 18/14389-0 - Brazil-UK Centre for Arbovirus Discovery, Diagnosis, Genomics and Epidemiology (CADDE)
Grantee:Ester Cerdeira Sabino
Support type: Research Projects - Thematic Grants
FAPESP's process: 19/03859-9 - Clinical, serological and virological characteristics of Dengue virus serotype 2 (DENV-2) infection in a cohort previously exposed to serotype 1
Grantee:Camila Malta Romano
Support type: Regular Research Grants
FAPESP's process: 19/24251-9 - Multi-omic approaches for the study of Chikungunya disease
Grantee:William Marciel de Souza
Support type: Scholarships abroad - Research Internship - Post-doctor
FAPESP's process: 17/13981-0 - Characterization, genomics and diagnostic of viruses with importance for public health in Brazil by high throughput sequencing
Grantee:William Marciel de Souza
Support type: Scholarships in Brazil - Post-Doctorate